Skip to main content

Clorox Stock Plunges Premarket After Q4 Earnings Miss, Revenue Decline, Gloomy FY22 Outlook

Clorox Co reported a fourth-quarter FY21 sales decline of 9.2% year-on-year, to $1.80 billion, missing the analyst consensus estimate of $1.92 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.